Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Swegon (1) (1)
Mandate

Vinge advises Swegon

May 03, 2013

Vinge has advised Swegon AB in connection with the acquisition of Walter Meier (Klima Deutschland) GmbH, a leading German climate solutions distributor. Walter Meir has 111 employees and had a turnover of MEUR 37 in 2012. The acquisition is subject to the approval of the German Competition Authority (Bunderskartellamt) and it is anticipated that the transaction will be completed in June 2013.

Swegon AB is a leading producer and supplier of energy-efficient ventilation and climate control systems. Swegon is a wholly owned subsidiary of Investment AB Latour.

Vinge’s team consisted of partner Magnus Pauli and associate Gabriel Westin.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026